DoH: MenC vaccine

In summary, these changes are:

  • the removal of the 2nd dose at age 16 weeks from the routine schedule for infants
  • the introduction of an adolescent booster dose at around 14 years

This resource does not cover the actual administration techniques involved in vaccination against MenC. Information on immunisation by nurses and other health professionals is available from Immunisation against infectious disease, Green Book.

Studies show that vaccination against meningococcal C (MenC) disease in early childhood provides a relatively short-term protective immune response. Protection given by vaccination at 12 months wanes by the teenage years, but vaccination later in childhood provides higher levels of antibody that persist for longer.

This document summarises the changes to the schedule, and addresses likely technical questions about making the changes work in practice.

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s